Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kumar Emayan"'
Autor:
John Morser, Imadul Islam, Cornell Mallari, Elena Ho, Marc Adler, Kumar Emayan, Gary Phillips, Shendong Yuan, Marc Whitlow, Christopher W. West, David R. Light, Giovanna Gualtieri, Drew Sukovich, Ulrich Bothe, Zheng Chang, Kieu Chu, Judi Bryant, Deborah Chen, Caralee Schaefer, Brad O. Buckman
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:3372-3375
We report here the design and synthesis of a novel series of benzylamines that are potent and selective inhibitors of uPA with promising oral availability in rat. Further evaluation of one representative (ZK824859) of the new structural class showed
Autor:
Jeremy Fournier, Karen Chen, Artur K. Mailyan, Jeffrey J. Jackson, Brad O. Buckman, Kumar Emayan, Shendong Yuan, Ravi Rajagopalan, Shawn Misialek, Marc Adler, Michael Blaesse, Andreas Griessner, Armen Zakarian
Publikováno v:
Organic letters. 21(2)
A total synthesis of N-desmethyl thalassospiramide C, a unique strained macrocyclic proteobacterial depsipeptide, enabled a detailed crystallographic study of its covalent complex with cathepsin K, a member of a medicinally important family of cystei
Autor:
Mariko Nagashima, Kumar Emayan, Imadul Islam, William P. Dole, Lei Zhao, Shendong Yuan, Yi-Xin Wang, Ronald Vergona, Kohichi Kawai, Mark E. Sullivan, Brad O. Buckman, John Morser, Junko Hosoya, Jon Vincelette, Valdeci da Cunha
Publikováno v:
Thrombosis and Haemostasis. 97:54-61
SummaryWe have discovered a novel small-molecule TAFIa inhibitor, BX 528, which is potent, highly selective against other carboxypeptidases and safe. The present study was to determine if BX 528 can enhance exogenous and endogenous thrombolysis in fo
Autor:
Deborah Chen, Damian O. Arnaiz, Wei-Wei Li, Feldman Richard, James M. Wu, Marc Whitlow, Shendong Yuan, Mike Ferrer, Brad Buckman, Judi Bryant, Mark A. Polokoff, Daguang Zhu, Bob Mintzer, Zheng Chang, Kumar Emayan, Sandra L. Biroc, Harald Dinter, Xue Snow Ge, Jih-Lie Tseng, Marc Adler, Jian-Ming Gu, Takashi Sato, Jun Shen
Publikováno v:
Chemical biologydrug design. 74(1)
Heat-shock protein-90 is an attractive target for anticancer drugs, as heat-shock protein-90 blockers such as the ansamycin 17-(allylamino)-17-demethoxygeldanamycin greatly reduce the expression of many signaling molecules that are disregulated in ca
Autor:
Imadul Islam, Paul Hrvatin, Kieu Chu, Marc Whitlow, Brad O. Buckman, Marc Adler, Drew Sukovich, John Morser, Christopher West, Shendong Yuan, Judi Bryant, Zheng Chang, Kumar Emayan
Publikováno v:
Acta crystallographica. Section D, Biological crystallography. 64(Pt 2)
This article reports the crystal structures of inhibitors of the functional form of thrombin-activatable fibrinolysis inhibitor (TAFIa). In vivo experiments indicate that selective inhibitors of TAFIa would be useful in the treatment of heart attacks
Autor:
Ronald Vergona, John Morser, Jon Vincelette, Mariko Nagashima, Lei Zhao, Judi Bryant, Kumar Emayan, Wei-Wei Li, Shendong Yuan, Paul Hrvatin, Babu Subramanyam, Drew Sukovich, Imadul Islam, Brad O. Buckman, David R. Light, Yi-Xin Wang
Publikováno v:
Thrombosis and haemostasis. 97(1)
SummaryWe have discovered a novel small-molecule (3-phosphinoylpropionic acid) inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa), BX 528, which had an IC50 of 2 nM in an enzymatic assay and 50 nM in an in-vitro clot lysis ass